Login

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma 00:00:00

Share On Facebook Share On Twitter

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Standard Bank's Strategic Expansion in Africa: Fueling Growth Beyond South Africa | Sim Tshabalala, CEO, Standard Bank.
00:10:00
Accelerating biomedical innovation by connecting science finance and commerce|Dr Suzanne Dilly,Chief Executive Officer,ValiRx
00:00:00
Practicing emergency physician / John D. Halamka, MD, MS Professor of Medicine Harvard Medical School
00:10:00
Pro Bono Publico Award: Honoring Simpson Thacher & Bartlett LLP's Commitment to Public Service | Alden Millard - Partner,Chair of the Executive Committee of Simpson Thacher
00:10:00
Amplify Energy (AMPY) Company Presentation at EnerCom Denver 2023 | Martyn Willsher, CEO, Amplify Energy CorpAMPY:NYQ
00:10:00
DoTerra Royalties (ASX: DTRO): Australian-Based Iron Ore Royalty Company Focused on Sustainable Growth and High Earnings
00:10:00
Wise CEO Talks Rebranding Strategy and Growth Outlook for the Fintech Leader | Kristo Käärmann ,CEO , Wise Plc.
00:10:00
Measuring and Fostering Innovation in Banks
00:10:00
Discovering the Depths: A Journey through Maritime History | Sim Tshabalala, CEO, Standard Bank.
00:10:00
Interview with DRD Gold CEO on Gold Market and Technological Innovations
00:10:00
focuses on for-profit enterprises with new products or business models|Amee Parbhoo,Managing Partner,Accion Venture Lab
00:10:00
Supporting the companies in the fastest and most effective ways|Xavier Niel,Founder,Kima Ventures

© 2017 - Neuhu+